From: US FDA; To: Supplement Industry – Tis The Season To Note Disease Claims, Undeclared Drugs

FDA wraps end-of-year greetings to supplement industry about drug-spiked products labeled as supplements in a bow with officials sharing annual update of their oversight of the industry during a food and drug regulation gathering.

• Source: Alamy

More from Compliance

More from Policy & Regulation